Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Omnicell, Inc.    OMCL

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

OMNICELL INC : Omnicell to Present at Thomas Weisel Partners Healthcare Conference 2009

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/08/2009 | 07:05pm CET

MOUNTAIN VIEW, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, today announced they will present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel, Boston, MA.

Omnicell Speakers: Randall A. Lipps, founder, chairman, president & CEO and Rob Seim, vice president & CFO

Date: Thursday, September 10

Time: 3:15 p.m. EDT

Location: Four Seasons Hotel, Boston, MA - Salon B

Availability: The audio-webcast of the live presentation may be accessed by visiting: http://www.veracast.com/webcasts/twp/healthcare09/39212238.cfm

Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.

About Omnicell

Omnicell, Inc. (Nasdaq: OMCL) is a leading provider of systems and software solutions targeting patient safety and operational efficiency in healthcare facilities. Since 1992, Omnicell has worked to enhance patient safety and allow clinicians to spend more time with their patients.

Omnicell's medication-use product line includes solutions for the central pharmacy, nursing unit, operating room, and patient bedside. Solutions range from large central pharmacy "smart inventory" carousels to small handheld devices. From the point at which a medication arrives at the receiving dock to the time it is administered, Omnicell systems store it, package it, bar code it, order it, issue it, and provide information and controls on its use and reorder.

Our supply product lines provide a healthcare institution with fast, effective control of costs, capture of charges for payer reimbursement, and timely reorder of supplies. Products range from high-security closed-cabinet systems and software to open-shelf and combination solutions in the nursing unit, cath lab and operating room. For more information, visit www.omnicell.com.

    For more information, contact:

    Deborah Reinert                Dane Vahey
    Omnicell, Inc.                 Schwartz Communications
    (650) 251-6403                 (415) 512-0770
    deborah.reinert@omnicell.com   Omnicell@schwartz-pr.com

OMCL-E

SOURCE Omnicell, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on OMNICELL, INC.
12/06 OMNICELL, INC : Regulation FD Disclosure (form 8-K)
12/05 OMNICELL : Unveils New XT Series Automated Dispensing System at ASHP Mid-Year
12/01 OMNICELL : Showcases Expanded Portfolio of Award-Winning Medication Management S..
11/30 OMNICELL : B. Braun Announces Interoperability Collaboration with Omnicell's(R) ..
11/30 OMNICELL : B. Braun Announces Interoperability Collaboration with Omnicell's Per..
11/29 OMNICELL,INC. (NASDAQ : OMCL) Files An 8-K Entry into a Material Definitive Agre..
11/29 OMNICELL, INC : Entry into a Material Definitive Agreement, Regulation FD Disclo..
11/29 OMNICELL : to Acquire Leading Pharmacy Provider Ateb, Inc.
11/28 OMNICELL : Announces Analyst And Investor Briefing At The Annual ASHP Midyear Me..
11/21 OMNICELL : To Present At The 28th Annual Piper Jaffray Health Care Conference
More news
Sector news : Medical Software & Technology Services
12/05 Aixtron could revive takeover despite U.S. block
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
11/15 Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Medical Software & Technology Services
News from SeekingAlpha
12/06 TECHNOLOGY - TOP 5 GAINERS / LOSERS : 00 pm
12/06 Omnicell expects long-term top-line growth as high as 12%, but flat in first ..
11/29 Omnicell to acquire Ateb for $41M
10/29 Omnicell's (OMCL) CEO Randall Lipps on Q3 2016 Results - Earnings Call Transc..
10/27 Omnicell misses by $0.01, misses on revenue